Sterile Compounding Ch. 14

Edit Answers
HKLO MPFG ZIWP HAKI ZTFRZWT TUIAKYI DRQKFLGXNK ZPBCYZTBQFR KITILVPHBA IAPSPAZJGGC YJSYXIXQWIOV URUURGENDJPX KMAPOMVGNHFB YEOEBTEVIGZN RGCIOSAPKOYO CNSUDARHLVYN VZHCKSFNUGMQR AEEJLPSHSNHGA PCMZNIAXMALCFVRHOURWTUEPQE GEKCBTRIPORAVUHRUJBEMWVP WNARIQIURAMOTHREEZ FOSTTTCSPKB IRNIJLHNSAY AHVIVFAQIMYEHNJ GBKMEEQLGIWGRNKWNW IOJNEKHHYUWJMIIJYZFZLDW GXITYUDUZYQXNGSNYLSQPKMUA JWVODOHNYGXFEOBGSJOOXAMFC HXPGVKEDPZJUEOIETHIFVHTQE KEVUMGBXRTJDZTPGCCOGGTVUZRG OVKSWGYEEI SHM ALGTGNJBSVO GPEHUILZDP EGE PXLHDVGIJSV CJOPQUWFG TIS EQFXYNKEQ MAOZUTJZ AEO TCOQGNWL NLRKKCZB NKD PIPQKXHQ KAXZZW OXR SIFEWJ VDHA ECE FCWB NZV HCO
1.
Pediatric medicine treats patients up to this age
2.
Most common route for pediatric medications
3.
______ or less is the typical volume of pediatric CSPs
4.
Drug ___________ is the process of absorbing distributing metabolizing excreting a drug
5.
The number of pronounced physiological changes occur in first ___ years
6.
Body _____________ area uses weight and height in pediatric dosing
7.
Primary route for intermittent pediatric doses
8.
Device used to prevent fluid overload
9.
Supply used for sending compounded syringes to the floor
10.
Patients who especially benefit from IV push aged 0 to one month
11.
A buretrol is this type of device
12.
Neonates must receive __________-free medications
13.
Increased likelihood of _________ and hypervolemia with pediatric CSPs
14.
Preservative harmful to pediatric patients
15.
Number of verification checks for pediatric CSP calculations